Scientists test antibiotic dosing in fight against severe pneumonia
NCT ID NCT04171674
Summary
This study aimed to understand how a strong antibiotic, ceftobiprole, moves through the bodies of very sick pneumonia patients who need breathing machines. Researchers measured drug levels in the blood and lungs of 12 patients to figure out the best dose to fight the infection. The goal was to gather data to help doctors use this antibiotic more effectively in intensive care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nîmes
Nîmes, Gard, 30029, France
-
Centre Hospitalier Lyon Sud,
Pierre-Bénite, Auvergne-Rhône-Alpes, 69310, France
Conditions
Explore the condition pages connected to this study.